UK markets close in 7 hours 44 minutes

Xeris Pharmaceuticals, Inc. (XERS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.8600+0.1100 (+6.29%)
At close: 04:00PM EDT
1.8699 +0.01 (+0.53%)
After hours: 07:40PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
67,449
121,966
67,271
37,598
Other short-term investments
5,002
0
35,162
96,190
Total cash
72,451
121,966
102,433
133,788
Net receivables
39,197
30,830
17,456
6,875
Inventory
38,838
24,735
18,118
8,353
Other current assets
5,778
9,287
4,589
3,196
Total current assets
156,264
186,818
142,596
152,212
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
35,211
15,042
10,762
9,258
Accumulated depreciation
-6,036
-5,534
-4,135
-2,551
Net property, plant and equipment
29,175
9,508
6,627
6,707
Equity and other investments
-
-
-
0
Goodwill
22,859
22,859
22,859
0
Intangible assets
109,764
120,607
131,450
-
Other long-term assets
4,540
4,730
829
232
Total non-current assets
166,338
157,704
161,765
6,939
Total assets
322,602
344,522
304,361
159,151
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
11,565
4,606
8,924
3,117
Accrued liabilities
28,703
40,204
44,491
13,890
Other current liabilities
20,276
2,658
1,987
322
Total current liabilities
95,193
73,621
79,040
28,207
Non-current liabilities
Long-term debt
190,932
187,075
88,067
87,021
Deferred tax liabilities
2,268
3,518
4,942
0
Other long-term liabilities
6,227
25,719
30,198
3,533
Total non-current liabilities
234,191
225,714
130,090
97,183
Total liabilities
329,384
299,335
209,130
125,390
Stockholders' equity
Common stock
14
14
13
6
Retained earnings
-617,025
-554,770
-460,110
-337,385
Accumulated other comprehensive income
-25
-23
-31
6
Total stockholders' equity
-6,782
45,187
95,231
33,761
Total liabilities and stockholders' equity
322,602
344,522
304,361
159,151